mRNA Victoria is a Victorian Government agency responsible for building a leading mRNA and RNA industry in the Asia Pacific region through strategic investments and partnerships that position Victoria at the forefront of mRNA innovation.

We advance the next generation of RNA-based therapies through industry leadership and advocacy and by investing in research, commercial and clinical scale manufacturing, targeted AI initiatives, clinical trials, and workforce training and supply chain development initiatives.

This includes supporting:

• Research and development of early stage and clinical research
• Research translation and commercialisation
• Commercial-scale manufacturing
• Clinical-scale manufacturing
• Supply chain development
• Clinical trials
• Workforce training
• AI initiatives.

Our role is to identify key capabilities, gaps and opportunities and to lead the Victorian Government’s engagement, investment and partnerships to grow the mRNA ecosystem and promote Victoria as the leading site in the Asia-Pacific for mRNA research, manufacturing, clinical trials, and workforce training.

mRNA Victoria supports the translation of research breakthroughs into the next generation of mRNA vaccines and medicines that will undergo clinical trials and be manufactured in Victoria.